These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2642629)

  • 41. Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
    Siostrzonek P; Koreny M; Delle-Karth G; Haumer M; Koller-Strametz J; Heinz G
    Acta Anaesthesiol Scand; 2000 Apr; 44(4):403-9. PubMed ID: 10757572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. General overview and update of positive inotropic therapy.
    Leier CV
    Am J Med; 1986 Oct; 81(4C):40-5. PubMed ID: 2946223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Milrinone. A clinical trial in 29 dogs with moderate to severe congestive heart failure.
    Keister DM; Kittleson MD; Bonagura JD; Pipers FS; Knauer KW
    J Vet Intern Med; 1990; 4(2):79-86. PubMed ID: 2187984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review: therapeutic concepts of congestive heart failure.
    Haustein KO
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
    Liu L; Zhao SP
    Int J Cardiol; 1999 Apr; 69(1):77-82. PubMed ID: 10362376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of imazodan for treatment of chronic congestive heart failure. The Imazodan Research Group.
    Goldberg AD; Nicklas J; Goldstein S
    Am J Cardiol; 1991 Sep; 68(6):631-6. PubMed ID: 1715125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the effects of isobutylmethylxanthine and milrinone on ischaemia-induced arrhythmias and platelet aggregation in anaesthetized rabbits.
    Holbrook M; Coker SJ
    Br J Pharmacol; 1989 Sep; 98(1):318-24. PubMed ID: 2478245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents.
    Simonton CA; Daly PA; Kereiakes D; Modin G; Chatterjee K
    Chest; 1987 Jul; 92(1):118-23. PubMed ID: 2954776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of inotropic support of the failing heart.
    Knight DH
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):879-904. PubMed ID: 1949498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enoximone and milrinone--inotropic vasodilators for severe heart failure.
    Drug Ther Bull; 1991 May; 29(10):39-40. PubMed ID: 1834448
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of chronic heart failure with positive inotropic agents].
    Lechat P
    Therapie; 1989; 44(6):437-45. PubMed ID: 2576155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure.
    Corbalán R; Jalil J; Chamorro G; Casanegra P; Valenzuela P
    Am J Cardiol; 1990 Mar; 65(9):644-9. PubMed ID: 2178384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of milrinone on ventricular arrhythmias in congestive heart failure.
    Ferrick KJ; Fein SA; Ferrick AM; Doyle JT
    Am J Cardiol; 1990 Aug; 66(4):431-4. PubMed ID: 2386119
    [No Abstract]   [Full Text] [Related]  

  • 54. Intravenous milrinone in treatment of advanced congestive heart failure.
    Zewail AM; Nawar M; Vrtovec B; Eastwood C; Kar MN; Delgado RM
    Tex Heart Inst J; 2003; 30(2):109-13. PubMed ID: 12809251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.
    Uretsky BF; Jessup M; Konstam MA; Dec GW; Leier CV; Benotti J; Murali S; Herrmann HC; Sandberg JA
    Circulation; 1990 Sep; 82(3):774-80. PubMed ID: 2144216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
    Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA
    Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT; Janicki JS; Jain MC
    J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
    Thackray S; Witte K; Clark AL; Cleland JG
    Eur J Heart Fail; 2000 Jun; 2(2):209-12. PubMed ID: 10856736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Physiological bases and therapeutic uses of inodilator drugs].
    Costa R; De Marino V; Marino A
    Clin Ter; 1991 Jan; 136(2):85-94. PubMed ID: 1827377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous milrinone in patients with severe congestive cardiac failure awaiting heart transplantation.
    Skoyles JR; Sherry KM; Price C
    J Cardiothorac Vasc Anesth; 1992 Apr; 6(2):222-5. PubMed ID: 1568013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.